04:14 AM EST, 01/21/2026 (MT Newswires) -- KKR (KKR) said late Tuesday it closed further investment in Sylvan, remaining the majority investor in the fungal biotechnology firm.
The funding round included capital from new global investors and a follow-on investment from Novo Holdings.
The round attracted commitments from TPG NewQuest, among others, KKR said.